The nurse discontinues the client's patient-controlled analgesia (PCA) pump. Which response should the nurse provide to the client's request to go to the smoking area?

Choice A reason: Bronchitis is not typically a contraindication for the use of methylphenidate. This medication primarily affects the central nervous system and has no direct impact on bronchitis.

Choice B reason: Hypertension is a critical condition to review before administering methylphenidate because this medication can increase blood pressure. Clients with pre-existing hypertension may be at risk for exacerbation of their condition, requiring careful monitoring and dosage adjustments.

Choice C reason: Diabetes mellitus does not present a direct contraindication for the use of methylphenidate. However, clients with diabetes should be monitored for any changes in blood glucose levels, as the stress response and changes in appetite can indirectly impact diabetes management.

Choice D reason: Hypercholesterolemia is not a primary concern when prescribing methylphenidate. While general health and cardiovascular risk factors should always be considered, hypercholesterolemia does not directly contraindicate the use of this medication.

Choice A reason: Although breastfeeding is not recommended while taking isotretinoin due to the potential for serious side effects, the most critical concern for a client planning to become pregnant is the teratogenic effects of the drug.

Choice B reason: While avoiding additional vitamin A is important to prevent toxicity, the priority for a client planning to conceive is to avoid the teratogenic effects of isotretinoin.

Choice C reason: Discontinuing isotretinoin one month before attempting to conceive is crucial because the drug is highly teratogenic and can cause severe birth defects. Ensuring the medication is out of the client's system before conception is the most important step to prevent harm to the fetus.

Choice D reason: Baseline liver function results are important for monitoring therapy, but they do not address the critical issue of preventing teratogenic effects in a client planning to become pregnant.